{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:54:25Z","timestamp":1787961265517,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>NR6A1 is a member of the nuclear receptor superfamily of ligand-activated transcription factors and can bind to conserved DNA sequences, acting as a transcriptional repressor. NR6A1 has been reported to promote prostate cancer, gastric cancer, and testicular germ cell tumor progression. In the present study, we confirmed the oncogenic role of NR6A1 in several types of cancer cells, including HeLa, TFK1, and A549 cells, and revealed that NR6A1 knockdown led to a decrease in lung adenocarcinoma cell proliferation, a reduction in glucose consumption, a reduction in lactic acid production, and decreases in ATP levels and mitochondrial membrane potential. Mechanistically, through a series of methods, including bioinformatics analysis, dual-luciferase reporter gene assay, RT-qPCR, Western blot analysis, and functional rescue experiments, we demonstrated that NR6A1 may promote the expression of HK1 by directly suppressing miR-302a, thereby reprogramming tumor cell glycolysis and enhancing lung adenocarcinoma cell growth. In addition, we found that NR6A1 can affect mTOR signaling, suggesting a broader role in tumor metabolism regulation. In summary, our data indicate that NR6A1 plays an oncogenic role by reprogramming glycolysis via the miR-302a\/HK1 axis in lung adenocarcinoma.<\/jats:p>","DOI":"10.1186\/s40659-025-00646-x","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:44:08Z","timestamp":1762875848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The nuclear receptor NR6A1 plays an oncogenic role through reprogramming glycolysis in tumors"],"prefix":"10.1186","volume":"58","author":[{"given":"Xiaowen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxian","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8280-6407","authenticated-orcid":false,"given":"Zenghui enghui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"646_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"646_CR2","first-page":"358","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L, et al. Lactate Metabolism Hum Lung Tumors Cell. 2017;171:358\u201371.","journal-title":"Lactate Metabolism Hum Lung Tumors Cell"},{"key":"646_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2013.11.004","volume":"53","author":"F Yang","year":"2014","unstructured":"Yang F, Zhang H, Mei Y, et al. Reciprocal regulation of HIF-1\u03b1 and LincRNA-p21 modulates the Warburg effect. Mol Cell. 2014;53:88\u2013100.","journal-title":"Mol Cell"},{"key":"646_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phrs.2018.03.015","volume":"131","author":"AS Gomes","year":"2018","unstructured":"Gomes AS, Ramos H, Soares J, et al. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacol Res. 2018;131:75\u201386.","journal-title":"Pharmacol Res"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","volume":"33","author":"L Li","year":"2018","unstructured":"Li L, Liang Y, Kang L, et al. Transcriptional regulation of the Warburg effect in cancer by SIX1. Cancer Cell. 2018;33:368\u2013e3857.","journal-title":"Cancer Cell"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0014-5793(98)01327-1","volume":"439","author":"UM Bauer","year":"1998","unstructured":"Bauer UM, Schneider-Hirsch S, Reinhardt S, et al. The murine nuclear orphan receptor GCNF is expressed in the XY body of primary spermatocytes. FEBS Lett. 1998;439:208\u201314.","journal-title":"FEBS Lett"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0014-5793(98)00142-2","volume":"424","author":"IY Agoulnik","year":"1998","unstructured":"Agoulnik IY, Cho Y, Niederberger C, et al. Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF. FEBS Lett. 1998;424:73\u20138.","journal-title":"FEBS Lett"},{"key":"646_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1128\/MCB.21.2.663-677.2001","volume":"21","author":"AC Chung","year":"2001","unstructured":"Chung AC, Katz D, Pereira FA, et al. Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior Truncation. Mol Cell Biol. 2001;21:663\u201377.","journal-title":"Mol Cell Biol"},{"key":"646_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1357-2725(01)00081-4","volume":"33","author":"AC Chung","year":"2001","unstructured":"Chung AC, Cooney AJ. Germ cell nuclear factor. Int J Biochem Cell Biol. 2001;33:1141\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"e103985","DOI":"10.1371\/journal.pone.0103985","volume":"9","author":"S Davood","year":"2014","unstructured":"Davood S, Xueping X, Chung AC. Germ cell nuclear factor regulates gametogenesis in developing gonads. PLoS ONE. 2014;9:e103985.","journal-title":"PLoS ONE"},{"key":"646_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D","volume":"50","author":"GC Hummelke","year":"1998","unstructured":"Hummelke GC, Meistrich ML, Cooney AJ. Mouse Protamine genes are candidate targets for the novel orphan nuclear receptor, germ cell nuclear factor. Mol Reprod Dev. 1998;50:396\u2013405.","journal-title":"Mol Reprod Dev"},{"key":"646_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pros.22659","volume":"73","author":"R Mathieu","year":"2013","unstructured":"Mathieu R, Evrard B, Fromont G, et al. Expression screening of cancer\/testis genes in prostate cancer identifies NR6A1 as a novel marker of disease progression and aggressiveness. Prostate. 2013;73:1103\u201314.","journal-title":"Prostate"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"64427","DOI":"10.18632\/oncotarget.11749","volume":"8","author":"G Cheng","year":"2016","unstructured":"Cheng G, Wang S, Li X, et al. Positive expression of NR6A1\/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients. Oncotarget. 2016;8:64427\u201339.","journal-title":"Oncotarget"},{"key":"646_CR15","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1113\/EP088399","volume":"105","author":"W Zhou","year":"2020","unstructured":"Zhou W, Jiang R, Wang Y, Li Y, Sun Z, Zhao H. hsa_circ_001653 up-regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA-377. Exp Physiol. 2020;105:2141\u201353.","journal-title":"Exp Physiol"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"9107","DOI":"10.1002\/cam4.3498","volume":"9","author":"X Liu","year":"2020","unstructured":"Liu X, Fan Z, Li Y, Li Z, Zhou Z, Yu X, Wan J, Min Z, Yang L, Li. D.microRNA-196a-5p inhibits testicular germ cell tumor progression via NR6A1\/E-cadherin axis. Cancer Med. 2020;9:9107\u201322.","journal-title":"Cancer Med"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/or.2025.8886","volume":"53","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhao J, Zhao S, Li J, Luo J, Wang Y. PFKFB4 promotes endometrial cancer by regulating Glycolysis through SRC-3 phosphorylation. Oncol Rep. 2025;53:53.","journal-title":"Oncol Rep"},{"key":"646_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/carcin\/bgae025","volume":"45","author":"S Yang","year":"2024","unstructured":"1.Yang S, Tang W, Azizian A, Gaedcke J, Ohara Y, Cawley H, Hanna N, Ghadimi M, Lal T, Sen S, Creighton CJ, Gao J, Putluri N, Ambs S. Hussain, P. MIF\/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Carcinogenesis. 2024;45:582\u201394.","journal-title":"Carcinogenesis"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12964-019-0389-4","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wan X, Hao Y, et al. NR6A1 regulates lipid metabolism through mammalian target of Rapamycin complex 1 in HepG2 cells. Cell Commun Signal. 2019;17:77.","journal-title":"Cell Commun Signal"},{"key":"646_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"646_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current Understanding. J Physiol. 2021;599:1745\u201357.","journal-title":"J Physiol"},{"key":"646_CR22","doi-asserted-by":"publisher","first-page":"e0116771","DOI":"10.1371\/journal.pone.0116771","volume":"10","author":"L Li","year":"2015","unstructured":"Li L, Liu D, Qiu ZX, Zhao S, Zhang L, Li WM. The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis. PLoS ONE. 2015;10:e0116771.","journal-title":"PLoS ONE"},{"key":"646_CR23","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-08-2138","volume":"15","author":"G Yu","year":"2009","unstructured":"Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, et al. Overexpression of phosphorylated mammalian target of Rapamycin predicts lymph node metastasis and prognosis of Chinese patients with gastric cancer. Clin Cancer Res. 2009;15:1821\u20139.","journal-title":"Clin Cancer Res"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1756-9966-28-152","volume":"28","author":"L Xiao","year":"2009","unstructured":"Xiao L, Wang YC, Li WS, Du Y. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. J Exp Clin Cancer Res. 2009;28:152.","journal-title":"J Exp Clin Cancer Res"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tranon.2016.01.001","volume":"9","author":"HA Azim","year":"2016","unstructured":"Azim HA, Kassem L, Treilleux I, Wang Q, El Enein MA, Anis SE, et al. Analysis of PI3K\/mTOR pathway biomarkers and their prognostic value in women with hormone Receptor-Positive, HER2-Negative early breast cancer. Transl Oncol. 2016;9:114\u201323.","journal-title":"Transl Oncol"},{"key":"646_CR26","first-page":"3882","volume":"8","author":"S Wu","year":"2015","unstructured":"Wu S, Sun C, Tian D, Li Y, Gao X, He S, et al. Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer. Int J Clin Exp Pathol. 2015;8:3882\u201391.","journal-title":"Int J Clin Exp Pathol"},{"key":"646_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ol.2015.3228","volume":"10","author":"Q Lu","year":"2015","unstructured":"Lu Q, Wang J, Yu G, Guo T, Hu C, Ren P. Expression and clinical significance of mammalian target of rapamycin\/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue. Oncol Lett. 2015;10:277\u201382.","journal-title":"Oncol Lett"},{"key":"646_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1471-2407-14-376","volume":"14","author":"S Li","year":"2014","unstructured":"Li S, Kong Y, Si L, Chi Z, Cui C, Sheng X, et al. Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma. BMC Cancer. 2014;14:376.","journal-title":"BMC Cancer"},{"key":"646_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9\u201322.","journal-title":"Cancer Cell"},{"key":"646_CR30","doi-asserted-by":"crossref","unstructured":"Adjei AA, Hidalgo M. (2005) Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol. 23; 5386\u2009\u2013\u2009403.","DOI":"10.1200\/JCO.2005.23.648"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd2062","volume":"5","author":"S Faivre","year":"2006","unstructured":"Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 2006;5:671\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.abb2683","volume":"371","author":"K Xu","year":"2021","unstructured":"Xu K, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371:405.","journal-title":"Science"},{"key":"646_CR33","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-21-2647","volume":"81","author":"AM Hosios","year":"2021","unstructured":"Hosios AM, Manning BD. Cancer signaling drives cancer metabolism: AKT and the Warburg effect. Cancer Res. 2021;81:4896\u20138.","journal-title":"Cancer Res"},{"key":"646_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K D\u00fcvel","year":"2010","unstructured":"D\u00fcvel K, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39:171\u201383.","journal-title":"Mol Cell"},{"key":"646_CR35","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1074\/jbc.M115.694208","volume":"291","author":"H Wang","year":"2016","unstructured":"Wang H, Xu X, Kyba X, Cooney M. Germ cell nuclear factor (GCNF) represses Oct4 expression and globally modulates gene expression in human embryonic stem (hES) cells. J Biol Chem. 2016;291:8644\u201352.","journal-title":"J Biol Chem"},{"key":"646_CR36","doi-asserted-by":"publisher","first-page":"33497","DOI":"10.1074\/jbc.M606975200","volume":"281","author":"M Hentschke","year":"2006","unstructured":"Hentschke M, Kurth I, Borgmeyer U, Hubner CA. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3. J Biol Chem. 2006;281:33497\u2013504.","journal-title":"J Biol Chem"},{"key":"646_CR37","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1093\/emboj\/cdg405","volume":"22","author":"ZJ Lan","year":"2003","unstructured":"Lan ZJ, Gu P, Xu X, Jackson KJ, DeMayo FJ, O\u2019Malley BW, Cooney AJ. GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility. EMBO J. 2003;22:4070\u201381.","journal-title":"EMBO J"},{"key":"646_CR38","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/stem.1689","volume":"32","author":"H Wang","year":"2014","unstructured":"Wang H, Wang X, Archer TK, et al. GCNF-dependent activation of Cyclin D1 expression via repression of Mir302a during ESC differentiation. Stem Cells. 2014;32:1527\u201337.","journal-title":"Stem Cells"},{"key":"646_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ygyno.2015.06.036","volume":"138","author":"J Han","year":"2015","unstructured":"Han J, Zhang L, Guo H, et al. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK\/mTOR\/S6 and MAPK signaling. Gynecol Oncol. 2015;138:668\u201375.","journal-title":"Gynecol Oncol"},{"key":"646_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.it.2019.12.006","volume":"41","author":"L Zhao","year":"2020","unstructured":"Zhao L, Hu H, Gustafsson J\u00c5, Zhou S. Nuclear receptors in cancer inflammation and immunity. Trends Immunol. 2020;41:172\u201385.","journal-title":"Trends Immunol"},{"key":"646_CR41","doi-asserted-by":"publisher","first-page":"14420","DOI":"10.1038\/ncomms14420","volume":"8","author":"XL Bian","year":"2017","unstructured":"Bian XL, Chen HZ, Yang PB, Li YP, Zhang FN, Zhang JY, Wang WJ, Zhao WX, Zhang S, Chen QT, Zheng Y, Sun XY, Wang XM, Chien KY, Wu Q. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate Carboxykinase sumoylation. Nat Commun. 2017;8:14420.","journal-title":"Nat Commun"},{"key":"646_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbrc.2019.11.079","volume":"522","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen F, Li S, et al. ERG the modulates Warburg effect and tumor progression in cervical cancer. Biochem Biophys Res Commun. 2020;522:191\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"646_CR43","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1097\/RLU.0000000000003055","volume":"45","author":"K Kozaka","year":"2020","unstructured":"Kozaka K, Kobayashi S, Takamura H, et al. Differences in 18F-FDG uptake and expression of glucose transporter between 2 distinct subtypes of Mass-Forming intrahepatic cholangiocarcinomas. Clin Nucl Med. 2020;45:e267\u201373.","journal-title":"Clin Nucl Med"},{"key":"646_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/08830185.2015.1018418","volume":"34","author":"F Grizzi","year":"2015","unstructured":"Grizzi F, Mirandola L, Qehajaj D, et al. Cancer-testis antigens and immunotherapy in the light of cancer complexity. Int Rev Immunol. 2015;34:143\u201353.","journal-title":"Int Rev Immunol"},{"key":"646_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.semcancer.2021.04.016","volume":"76","author":"C Fan","year":"2021","unstructured":"Fan C, Qu H, Wang X, et al. Cancer\/testis antigens: from serology to mRNA cancer vaccine. Semin Cancer Biol. 2021;76:218\u201331.","journal-title":"Semin Cancer Biol"},{"key":"646_CR46","first-page":"967","volume":"20","author":"KA Babatunde","year":"2017","unstructured":"Babatunde KA, Najafi A, Salehipour P, et al. Cancer\/Testis genes in relation to sperm biology and function. Iran J Basic Med Sci. 2017;20:967\u201374.","journal-title":"Iran J Basic Med Sci"},{"key":"646_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393.","journal-title":"Cell"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-025-00646-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:18:43Z","timestamp":1762881523000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-025-00646-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1186\/s40659-025-00646-x","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}